Phenprocoumon

Revision as of 17:08, 19 December 2011 by Vanbot (talk | contribs) (Protected "Phenprocoumon": Robot: Protecting all pages from category Drug ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Phenprocoumon
Clinical data
ATC code
Pharmacokinetic data
Protein binding99%
Metabolismhepatic to inactive metabolites
Elimination half-life5 to 6 days
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H16O3
Molar mass280.318 g/mol

WikiDoc Resources for Phenprocoumon

Articles

Most recent articles on Phenprocoumon

Most cited articles on Phenprocoumon

Review articles on Phenprocoumon

Articles on Phenprocoumon in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phenprocoumon

Images of Phenprocoumon

Photos of Phenprocoumon

Podcasts & MP3s on Phenprocoumon

Videos on Phenprocoumon

Evidence Based Medicine

Cochrane Collaboration on Phenprocoumon

Bandolier on Phenprocoumon

TRIP on Phenprocoumon

Clinical Trials

Ongoing Trials on Phenprocoumon at Clinical Trials.gov

Trial results on Phenprocoumon

Clinical Trials on Phenprocoumon at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenprocoumon

NICE Guidance on Phenprocoumon

NHS PRODIGY Guidance

FDA on Phenprocoumon

CDC on Phenprocoumon

Books

Books on Phenprocoumon

News

Phenprocoumon in the news

Be alerted to news on Phenprocoumon

News trends on Phenprocoumon

Commentary

Blogs on Phenprocoumon

Definitions

Definitions of Phenprocoumon

Patient Resources / Community

Patient resources on Phenprocoumon

Discussion groups on Phenprocoumon

Patient Handouts on Phenprocoumon

Directions to Hospitals Treating Phenprocoumon

Risk calculators and risk factors for Phenprocoumon

Healthcare Provider Resources

Symptoms of Phenprocoumon

Causes & Risk Factors for Phenprocoumon

Diagnostic studies for Phenprocoumon

Treatment of Phenprocoumon

Continuing Medical Education (CME)

CME Programs on Phenprocoumon

International

Phenprocoumon en Espanol

Phenprocoumon en Francais

Business

Phenprocoumon in the Marketplace

Patents on Phenprocoumon

Experimental / Informatics

List of terms related to Phenprocoumon

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Phenprocoumon is an anticoagulant, functioning as a Vitamin K antagonist. It is a derivative of coumarin and is also marketed under the brand name Marcoumar. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders.

It is marketed as Marcoumar by Roche.

External links


Template:SIB

Template:WikiDoc Sources

de:Phenprocoumon